Relatively little is known about the neuropathophysiology of binge-eating disorder (BED). Here, the evidence from neuroimaging, neurocognitive, genetics, and animal studies are reviewed to synthesize our current understanding of the pathophysiology of BED. Binge-eating disorder may be conceptualized as an impulsive/compulsive disorder, with altered reward sensitivity and food-related attentional biases. Neuroimaging studies suggest there are corticostriatal circuitry alterations in BED similar to those observed in substance abuse, including altered function of prefrontal, insular, and orbitofrontal cortices and the striatum. Human genetics and animal studies suggest that there are changes in neurotransmitter networks, including dopaminergic and opioidergic systems, associated with binge-eating behaviors. Overall, the current evidence suggests that BED may be related to maladaptation of the corticostriatal circuitry regulating motivation and impulse control similar to that found in other impulsive/compulsive disorders. Further studies are needed to understand the genetics of BED and how neurotransmitter activity and neurocircuitry function are altered in BED and how pharmacotherapies may influence these systems to reduce BED symptoms.
Introduction
Binge-eating disorder (BED) is the most prevalent eating disorder (Hudson et al., 2007; Kessler et al., 2013) and is now included in the main section of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013) . Despite its high prevalence, the etiology of BED remains understudied, and the underlying neurobiological features of the disorder are poorly understood (Schienle et al., 2009 ). This article reviews human neuroimaging, neurocognitive and genetic BED data (Table 1 ) and considers complementary animal data relating to binge eating. Data suggest that compared with individuals without BED (hereafter referred to as non-BED), individuals with BED have greater cognitive attentional biases towards food, decreased reward sensitivities, and altered brain activation in regions associated with impulsivity and compulsivity. It is worth noting at the outset of this review that the concept "food addiction" is an ongoing area of research, with several recent reviews addressing this topic in relation to obesity and eating disorders in great detail (Hebebrand et al., 2014; Meule, 2015; Meule and Gearhardt, 2014; Potenza and Grilo, 2014) . Furthermore, available evidence suggests stress and emotional regulation may play a role in BED (Corwin et al., 2011; Gianini et al., 2013; Gluck et al., 2004; Hilbert et al., 2011; Laessle and Schulz, 2009; Larsen et al., 2009; Nicholls et al., 2016; Pendleton et al., 2001; Pinaquy et al., 2003; Rosenberg et al., 2013; Schulz and Laessle, 2012) . However, as these models are not the main focus of this review, they are only briefly discussed.
Impulsivity-related constructs and other cognitive functions

Impulsivity and compulsivity
Impulsivity reflects decision-making occurring with limited forethought and represents a multidimensional construct involving tendencies to act rashly, to have increased reward-related drives, and to have disadvantageous decision-making (Dawe and Loxton, 2004) . In contrast, compulsivity is characterized by the performance of repetitive and persistent actions that are not related to an overall goal or reward and that can persist despite adverse consequences (Dalley et al., 2011) . Increased impulsivity, elevated compulsivity, and altered reward sensitivity/punishment are reported in BED (Carrard et al., 2012; Duchesne et al., 2010; Galanti et al., 2007; Manwaring et al., 2011; Schag et al., 2013; Wu et al., 2014; Wu et al., 2013) . Compared with non-BED obese and normal weight individuals, those with BED have increased impulsivity scores on the Barratt (BIS-11) and UPPS impulsiveness scales, decreased self-control, and impaired set-shifting reflective of perseverative/compulsive behaviors (Danner et al., 2012; Duchesne et al., 2010; Fineberg et al., 2014; Galanti et al., 2007; Hege et al., 2015; Manwaring et al., 2011; Schag et al., 2013; Wu et al., 2014; Wu et al., 2013) . Impulsivity may underlie the diminished control observed during binge-eating episodes in BED, as higher BIS-11 scores were correlated with larger test meal intake (Galanti et al., 2007) . Altered reward sensitivity is observed in overweight/obese BED individuals, as shown by gazing longer at food-related cues during a visual saccade task, with BED individuals having more difficulty inhibiting saccades toward both food-and non-foodrelated stimuli . Comorbid depressive symptoms and low self-esteem in individuals with BED are associated with greater impulsivity and sensitivity to punishment (Carrard et al., 2012) . Taken together, the behavioral alterations observed in BED individuals indicate that BED may be conceptualized as an impulsive/compulsive disorder.
Other cognitive functions
Cognitive deficits in executive function, inhibitory control, attention, and mental flexibility are also reported in individuals with BED (Boeka and Lokken, 2011; Duchesne et al., 2010; Mobbs et al., 2011) . Obese BED individuals exhibit broad cognitive dysfunction compared with obese non-BED individuals on tasks assessing problem solving, plan formulation and implementation, task scheduling, performance monitoring, cognitive flexibility, and working memory (Duchesne et al., 2010) . Obese BED individuals also perform worse than obese non-BED individuals in multiple behavioral-tendency domains (apathy, disinhibition, executive dysfunction) related to prefrontal cortical function (Boeka and Lokken, 2011) . While obese BED individuals exhibited impaired inhibitory control, attention, and rates of learning compared with obese non-BED individuals, BED and non-BED obese individuals performed worse than normal-weight individuals, suggesting that obesity alone may be related to impaired functioning (Mobbs et al., 2011) .
Food-related attentional and memory biases
Individuals with BED have been shown to exhibit altered attentional and memory biases regarding food-related cues, and to a lesser extent, body-image-related cues Svaldi et al., 2010a Svaldi et al., , 2014 . Overweight women with BED preferentially attended to food-related stimuli compared with overweight non-BED women, including faster identification of visually obscured food-related words than non-food-related words and a faster fixation on a spatial cue located in the same vicinity as a foodrelated image . Overweight individuals with BED showed more cognitive interference during performance of a working-memory task than those without BED, regardless of whether the interfering cues were food-related . However, cognitive interference in BED individuals was greater after exposure to food-related stimuli than to neutral stimuli and was substantially greater compared with non-BED individuals when stimuli were presented in a manner representative of everyday situations . These alterations highlight the differential response of BED individuals to environmental cues, particularly to cues related to food.
Decision-making impairment
Decision-making impairments may also be associated with BED. In a probabilistic-reward task, individuals with BED made riskier decisions than non-BED individuals (Svaldi et al., 2010b) . Obese individuals with BED also showed reduced preference for delayed rewards and probabilistic rewards compared with obese non-BED individuals and normal-weight individuals, suggesting that impaired decision-making may relate in part to impatience and risk aversion (Manwaring et al., 2011) . BED-related decision-making • There were no significant group differences in monetary incentive delay task performance between treatment nonresponders (n = 10) and treatment responders (n = 9) • Treatment nonresponders showed reduced ventral striatal and inferior frontal gyrus recruitment during the anticipatory phase of reward processing and reduced activity in the medial prefrontal cortex during the outcome phase of reward processing compared with treatment responders Cambridge et al. (2013) fMRI Obese individuals with BED were treated with either placebo (n = 21) or a -opioid receptor antagonist (GSK1521498; n = 21); grip force was measured in response to high-or low-caloric food images and high-or low-reward nonfood images to ascertain the effort participants were willing to expend to view these images Karhunen et al. (2000) SPECT Obese women with BED (n = 8), obese women without BED (n = 11), and normal-weight women (n = 12) were exposed to a control stimulus (landscape picture) and to a food stimulus (warm freshly cooked lunch)
• Obese women with BED exhibited increases in blood flow in the left frontal and prefrontal cortices in response to the food stimulus; obese individuals without BED and normal-weight individuals showed no change or localized increases in the right hemisphere Kuikka et al. (2001) SPECT Radioligand-labeled serotonin transporter binding was recorded in obese women with BED (n = 11) and obese women without BED (n = 7)
• Obese women with BED showed decreased midbrain serotonin transporter binding relative to obese women without BED Hege et al. (2015) MEG Overweight/obese women with BED (n = 17) and without BED (n = 17) were assessed on the Barratt Impulsiveness Scale and in a food-related "go/no-go" task
• Individuals with BED tended to score higher on the Barratt Impulsiveness Scale; "no-go" accuracy tended to worsen more often in individuals with BED in response to food-related stimuli • Individuals with BED did not have a food-specific prefrontal cortical activity increase during the "go/no-go" task Glucocorticoid receptor gene SNPs were examined in individuals with BED (n = 62) and in obese (n = 177) and normal-weight (n = 107) individuals without eating disorders
• The GG genotype of the rs6198 polymorphism occurred more frequently in individuals with BED than in normal-weight controls; the frequency of this genotype in individuals with BED was also elevated in individuals with BED compared with obese individuals without BED, but the difference was not statistically significant Individuals with BED (n = 32) and aged-matched non-obese controls without BED (n = 46) were assessed for DAT1 genotypes and for hunger after exposure to a food stimulus after MPH
• Individuals with BED with the 9-repeat DAT1 allele (which is associated with decreased DAT protein and increased synaptic dopamine) showed more appetite suppression following MPH than controls without BED possessing the same allele or any individual possessing the 10-repeat allele (associated with increased DAT protein and decreased synaptic dopamine) 
FAAH gene Overweight/obese women with BED (n = 115), overweight/obese women without BED (n = 74), and normal-weight women without BED (n = 110) were assessed for a FAAH gene polymorphism (cDNA 385C to A), which impacts the degradation of endocannabinoids
• Genotype and allele frequencies did not differ between obese individuals with and without BED
Tasca et al. (2013) IGF-II isoforms
Overweight women with BED (n = 97), overweight women without BED (n = 53), and normal-weight women without BED (n = 50) were assessed for the IGF-II isoforms before and after group psychotherapy
• The mature isoform of IGF-II was significantly higher in obese women with BED compared with normal-weight women without BED, but there were no significant differences between obese women with and without BED • The BIG IGF-II isoform decreased after group psychotherapy, but no difference was reported between obese women with and without BED • BED aggregated in families, with an estimated heritability of 57% Obese individuals with BED (n = 16), obese individuals without BED (n = 16), and normal-weight individuals (n = 16) were assessed on a food/body-mental flexibility task
• Obese individuals with BED made more errors and omissions than obese individuals without BED and normal-weight controls in the food and body sections of the task, indicating impaired attention and inhibitory control • Obese individuals with BED exhibited less within-session learning than obese individuals without BED, as evidenced by omission rates across sessions Schag et al. (2013) Attention, inhibitory control
Overweight/obese individuals with BED (n = 25), overweight/obese individuals without BED (n = 26), and normal-weight individuals without BED (n = 25) were assessed for reward sensitivity and disinhibition in response to food stimuli using visual saccade tracking
• Individuals with BED gazed longer at food stimuli (increased reward sensitivity) and had more difficulty inhibiting saccades toward both food and nonfood stimuli (disinhibition/inhibitory control) than both obese individuals without BED and normal-weight individuals without BED Schmitz et al. (2014) Attention, attentional bias
Overweight/obese women with BED (n = 27) and overweight/obese women without BED (n = 33) were assessed on a test of attentional vigilance in which they identified visually obscured words (food-related and neutral) and a spatial cueing task (food-related and neutral images) to examine attentional bias
• Both obese women with BED and obese women without BED identified obscured food-related words faster than neutral words, with the effect was more pronounced for those with BED • Response times of obese women with BED but not obese women without BED were more rapid in a spatial cueing task in response to food-related cues compared with neutral cues Svaldi et al. (2014) Attention, attentional bias
Overweight individuals with BED (n = 31) and overweight individuals without BED (n = 36) completed an n-back working memory tasks in the presence of interfering cues both food-related and neutral. Participants also performed a recent-probe task in which a set of words are presented for a short time each trial and then after a retention an interval, a probe stimulus is presented and the participant is asked to classify it as to whether it was a member of the most recent trial's words; the words used could be food-related or neutral.
• Overweight individuals with BED were more likely than those without BED to show cognitive interference in a working memory task that employed a highly familiar but irrelevant stimulus regardless of whether the interfering cues were food-related or neutral • Cognitive interference in individuals with BED was more pronounced after exposure to food-related stimuli than to neutral stimuli and substantially greater compared with individuals without BED when the working memory task employed more diverse stimuli in a manner that may be more representative of everyday situations Women with BED (n = 19), obese women without BED (n = 18), and normal-weight women without BED (n = 30) were assessed on the Iowa Gambling Task
• Obese women with BED and obese women without BED performed worse than normal-weight women, but obese women with BED did not perform worse than obese women without BED; task performance correlated with binge eating severity in the BED group Davis et al. (2010) Decisionmaking
Obese women with BED (n = 65), obese women without BED (n = 73), and normal-weight women without BED (n = 71) were tested on the Iowa Gambling Task and a Delay Discounting measure
• Obese women with BED and obese women without BED performed worse than normal-weight women on both tasks but did not differ from each other Manwaring et al.
Decisionmaking
Obese women meeting DSM-IV criteria for BED (n = 30), obese women without BED (n = 30), and normal-weight women without BED (n = 30) were assessed on decision-making using delay and probability discounting tasks
• Across reward types, obese women with BED showed a reduced preference for delayed rewards and probabilistic rewards compared with obese individuals without BED and normal-weight controls Svaldi et al. (2010b) Decisionmaking, cognitive flexibility
Overweight women meeting DSM-IV criteria for BED (n = 17) and overweight women without BED (n = 18) were assessed using the Game of Dice task and the Trail Making Test impairments were further delineated in a task in which participants could choose between risky or sure monetary choices (Voon et al., 2015b) . Obese individuals with BED were more likely than obese non-BED individuals and age-and gender-matched healthy volunteers to make risky choices in response to moderate probabilities of reward and high probabilities of loss (Voon et al., 2015b) , a decision-making pattern similar to that observed in abstinent alcohol-dependent and abstinent stimulant-dependent individuals but not obese individuals (Voon et al., 2015b) . Probabilities of making risky choices did not vary with reward magnitude in individuals with BED, whereas they decreased with increasing reward magnitude in age-and gender-matched healthy volunteers and obese non-BED individuals (Voon et al., 2015b) . Thus, individuals with BED may exhibit impaired decision-making in situations associated with high risk and ambiguity whereas obese non-BED individuals may be impaired more in ambiguous situations. However, in studies of BED cognitive and decision-making deficits are not always observed in obese BED versus obese non-BED individuals (Danner et al., 2012; Davis et al., 2010; Duchesne et al., 2010; Galioto et al., 2012; Wu et al., 2013) . Despite the fact that the degree of decision-making impairment on the Iowa Gambling Task correlates positively with binge-eating severity among BED individuals (Danner et al., 2012) , in one study obese BED and obese non-BED individuals exhibited similar cognitive impairments across multiple domains (memory, attention, executive function, language) (Galioto et al., 2012) and similar impairment on the Iowa Gambling Task (Danner et al., 2012; Davis et al., 2010) . These findings suggest that binge eating behaviors in BED individuals are not solely driven by alterations in cognitive function.
In summary, BED can be associated with an array of cognitive alterations related to impulsivity/compulsivity, executive function, attention, and decision making. These alterations suggest that altered function in the cortex and striatum, areas whose function plays a key role in mediating these cognitive functions (Berridge and Kringelbach, 2008; Bromberg-Martin et al., 2010; Everitt and Robbins, 2013; Miller and Cohen, 2001 ; Naqvi and Bechara, 2010), is altered in BED individuals. Available evidence regarding altered brain function in BED is summarized in the next section.
Brain structure and function
Neurophysiologic and neuroimaging studies have identified changes in individuals with BED that may partially underlie altered impulsivity and reward processing. Obese women with BED compared with non-BED obese women exhibited increased centroparietal cortical long-latency event-related potentials (an index of motivated attention) when viewing high-caloric food pictures but not neutral pictures (Svaldi et al., 2010c) . Increased frontal beta-electroencephalographic activity during resting and active states was observed in obese BED women compared with obese non-BED women; increased beta activity correlated with scores on the disinhibition factor of the Three-Factor Eating Questionnaire and Binge-Eating Scale in obese women with BED (Tammela et al., 2010) . Obese BED women also demonstrated increased regional cerebral blood flow in left frontal and prefrontal cortices in response to food stimuli, whereas non-BED and normal-weight women showed no change or only localized increases in the right hemisphere (Karhunen et al., 2000) . BED individuals compared with obese and normal-weight non-BED individuals exhibited increased reward responsiveness and increased medial orbitofrontal cortical activity in response to highcaloric food images, as assessed by functional magnetic resonance imaging (fMRI) (Schienle et al., 2009) . Taken together, these data suggest altered function in cortical and striatal regions is likely to contribute to BED.
Striatum and insular cortex
Striatal and insular function has been associated with reward sensitivity and impulsivity in BED. During exposure to high-caloric food images, activation in the left ventral striatum separated BED individuals from those with bulimia nervosa (BN), with a sensitivity of 82% and a specificity of 86%. Right ventralstriatal activation during exposure to high-calorie food images differentiated obese BED and non-BED individuals, with a sensitivity of 59% and a specificity of 82%; right-insular activation differentiated BED individuals from obese and normal-weight non-BED individuals, with sensitivities of 77% and 82%, respectively, and specificities of 65% and 90% (Weygandt et al., 2012) . Compared with non-BED individuals, obese individuals with BED demonstrated bilateral decreases in ventral-striatal activation during anticipation of monetary reward receipt/loss; upon notification of a monetary reward, obese BED individuals demonstrated diminished insular activity compared with non-BED obese and normal-weight individuals (Balodis et al., 2013a) . Obese BED individuals who continued to binge eat following treatment with sibutramine and/or psychotherapy had relatively decreased anticipation-related right ventral-striatal activation, anticipation-related bilateral-inferior-frontal-gyral activation, and outcome-related medial-prefrontal-cortical activation compared with those who did not continue to binge eat (Fig. 1) . Given links between anticipation-related ventral-striatal activation and impulsivity , these findings suggest possible links between reward-related brain activations, impulsivity, and treatment outcome in BED.
Prefrontal cortex and impulse-control networks
Altered cognitive function in BED may relate to reward sensitivity (Balodis et al., 2013b; Schafer et al., 2010; Voon et al., 2015a) . During fMRI Stroop performance, obese BED individuals showed (A) Coronal view (y = 12) of ventral striatal regions showing a whole brain contrast between obese individuals with binge eating disorder (BED; n = 19) and obese individuals without BED (OB; n = 19). (B) Map of differences within the BED group separating those who reported bingeing following treatment (BEpost-tx; n = 10) contrasted with BED participants who did not report bingeing following treatment (NBEpost-tx; n = 9). Brain activation maps demonstrate differences in the A2 winning phase (A2W; associated with the anticipation of potentially winning money). All contrast maps are thresholded at an uncorrected level of p < 0.05 two-tailed and family-wise-error corrected at p < 0.05. Blue color demonstrates areas where participants show relatively less activation. The right side of the brain is on the right. *Unpublished data obtained from Iris Balodis and Marc Potenza; see Balodis et al. (2014) for study description.
diminished activity in impulse control-related cortical areas (i.e., ventromedial-prefrontal, inferior-frontal, and insular) compared with non-BED individuals in the absence of differences in task performance (Balodis et al., 2013b) . During a habitual learning test, BED individuals were more likely than non-BED individuals to use habitual learning strategies and to show perseveration, with obese BED versus non-BED individuals demonstrating smaller left-ventral-striatal, bilateral-caudate, and orbital-frontal-cortical volumes (Voon et al., 2015a) . However, when behavior was covaried, group differences in the medial orbitofrontal cortex, caudate, and ventral striatum were no longer significant, suggesting that individual differences in learning bias may be related to these findings (Voon et al., 2015a) . Increased attentional impulsiveness measured on the BIS-ll was related to decreased response inhibition in a visual go-nogo task and to hypoactivity in prefrontal networks in obese BED and non-BED individuals, with BED indi-viduals exhibiting higher attentional impulsiveness scores and a trend towards worse performance in response to food-specific stimuli than non-BED individuals (Hege et al., 2015) . Results from a pilot study suggest that the level of hypoactivity in frontal cortical reward circuitry in BED relates to treatment response, with those with greater hypoactivity exhibiting persistent bingeing following treatment (Balodis et al., 2014) . Structural MRI has revealed differences in gray-matter volumes in the anterior-cingulate and medial-orbitofrontal cortices in BED individuals (Schafer et al., 2010) and selective atrophy in the right striatum, right ventralinsular cortex, and right orbitofrontal cortex (Woolley et al., 2007) in individuals with frontotemporal dementia who develop bingeeating behaviors. The precise clinical relevance of these findings remains to be determined. However, given the preponderance of evidence, it seems reasonable to hypothesize that altered cortical function contributes significantly to the altered reward sensitivity and impulsivity observed in BED individuals.
Genetics
BED aggregates in families (Hudson et al., 2006) ; heritability estimates for BED range from 41% to 57% (Javaras et al., 2008; Mitchell et al., 2010; Reichborn-Kjennerud et al., 2004) . As with most psychiatric disorders, the genetics of BED are likely to be complex and involve interactions with environmental factors (see Table 1 for descriptions of genetics studies). Therefore, multiple genetic studies have assessed potential substrates that might contribute to the neurobiologic alterations in BED.
Dopaminergic-and opioidergic-associated genetic polymorphisms
Compared with normal-weight non-BED individuals, obese BED and non-BED individuals have displayed elevated reward sensitivity if they carry ≥1 copy of the A1 allele of the Taq1A polymorphism (Davis et al., 2008) . This polymorphism is downstream of the DRD2 gene and is located within the ANKK1 gene (Neville et al., 2004) ; it is associated with reduced D2-like receptor density in healthy volunteers (Jonsson et al., 1999; Pohjalainen et al., 1998) and in alcohol-dependent individuals (Yang et al., 2007) . The allelic frequency of A1 is lower among obese BED individuals compared with obese non-BED individuals (Davis et al., 2009 (Davis et al., , 2012 . The A2 allele of the Taq1A polymorphism (known as rs1800497), which is associated with increased dopamine signaling (Noble et al., 1991) , and the rs6277 polymorphism of the DRD2 gene (known as C957T), which is associated with increased D2-like receptor binding in [ 11 C]raclopride studies (Hirvonen et al., 2004) , are more common in obese BED individuals than in obese non-BED individuals (Davis et al., 2009; Davis et al., 2012) . BED individuals with a copy of the 9-repeat allele of the dopamine transporter gene (DAT1), which is associated with decreased dopamine levels of transporter protein and increased levels of synaptic dopamine, exhibited more methylphenidate-induced appetite suppression than BED individuals who were homozygous for the 10-repeat allele and non-BED individuals regardless of genotype (Davis et al., 2007) .
The "gain of function" G allele (known as G + ) of the A118G polymorphism of the -opioid-receptor-encoding gene appears more common in obese individuals with BED than in obese non-BED individuals (Davis et al., 2009 ). The higher frequency of Taq1A A2/A118G G + genotypes observed in BED individuals suggests that these individuals may be prone to elevated food-related hedonic responses through dopaminergic and opioidergic influences on reward-related processes (Davis et al., 2009) .
All of these studies are interesting, but they involved relatively small samples (Table 1) . While replication studies are required to substantiate these findings, the evidence to date supports the concept that BED has genetic underpinnings that include altered dopaminergic systems that may contribute to impulsivity, compulsivity, and reward/reinforcement (Avena and Bocarsly, 2012; Buckholtz et al., 2010; Kenny et al., 2013; Nakanishi et al., 2014) .
Other polymorphisms
In addition to dopaminergic and opioidergic genes, serotonergic, glucocorticoid, brain-derived-neurotrophic-factor, CLOCK, endocannabinoid, and insulin-like-growth-factor-2 genes have been investigated (Cellini et al., 2010; Kuikka et al., 2001; Monteleone et al., 2006a Monteleone et al., , 2008a Monteleone et al., ,b, 2006b Tammela et al., 2003; Tasca et al., 2013) ; however, results have either been equivocal or suggested no association with BED. Although there are no published genomewide association studies in BED, a study comparing individuals with bipolar disorder who either exhibited or did not exhibit binge-eating behaviors reported multiple single-nucleotide polymorphisms in association with binge-eating behaviors (Winham et al., 2014) . As with all genetic association studies, it remains possible that the implicated genes are more related to specific disorder-associated domains (e.g., impulsivity, compulsivity, or reward sensitivity) rather than the disorder as a whole.
Translational considerations: animal and human data
BED is characterized by impulsive and compulsive consumption of highly palatable foods, which is regulated by brain reward systems (Avena and Bocarsly, 2012; Avena et al., 2008; Mathes et al., 2009) . Although multiple neurotransmitter systems (including dopaminergic, cholinergic, noradrenergic, opioidergic, GABAergic, and glutamatergic systems) may contribute to binge-eating behaviors, dopaminergic and opioidergic neurotransmission appear critical to reward, including reward-related food consumption (Avena and Bocarsly, 2012; Avena et al., 2008; Bello et al., 2014; DiFeliceantonio et al., 2012; Mathes et al., 2009 ). Dopaminergic neurotransmission in the nucleus accumbens/ventral striatum (NAc) is linked to motivational and energy-dependent aspects of food seeking and opioidergic neurotransmission is involved in hedonic aspects of reward (Castro and Berridge, 2014; Salamone et al., 2003; Wise, 2008) . Although the reduction in food consumption in animal models (Nathan and Bullmore, 2009) and the reduction in the motivation to view high-caloric food images in BED individuals (Cambridge et al., 2013 ) that occurs following the blockade of -opioid receptors suggest that opioid systems contribute to BED, treatment with -opioid receptor antagonists does not reduce binge eating in BED individuals (McElroy et al., 2013; Ziauddeen et al., 2013) . While food is a natural reward, data suggest that similar changes in dopaminergic neurotransmission in brain reward circuitry may underlie binge-eating behaviors (Furlong et al., 2014) and drug abuse (Everitt and Robbins, 2013) . These changes in dopaminergic neurotransmission may contribute to increased impulsivity, compulsive behaviors, and altered reward sensitivity seen in these disorders (Blum et al., 2014; Everitt and Robbins, 2013; Fineberg et al., 2014; Richard et al., 2013; Stice et al., 2013) .
Ventral midbrain-nucleus accumbens (NAc) dopaminergic pathways
Increased impulsivity has been associated with altered dopaminergic neurotransmission in the ventral midbrain and NAc. Studies in animals and healthy humans have reported that increased impulsivity is correlated with decreased ventral-striatal and ventral-midbrain dopamine D2-like receptor levels and with increased dopamine release in the anterior caudate and NAc (Belin et al., 2008; Buckholtz et al., 2010) . Pathway analysis suggests increased dopamine release in the NAc and anterior caudate observed with increased impulsivity is mediated by decreased ventral-midbrain dopamine D2-like receptor levels, with these receptors being autoreceptors on dopamine neurons regulating dopaminergic neuronal firing (Buckholtz et al., 2010) . In primates, initial rates of cocaine self-administration and acquisition of cocaine self-administration have been correlated with decreased NAc/striatal dopamine D2-like receptor levels (Nader et al., 2008) . Therefore, impulsivity may represent a critical risk factor for substance abuse, and this may be linked to altered dopamine D2-autoreceptor regulation of ventral-midbrain dopamine neurons, leading to increased dopamine neurotransmission in the NAc.
Studies in rodents indicate that the development of compulsive drug abuse and binge-eating reflect progressive changes in the locus of dopaminergic control of drug and food consumption from a reward/ventral-striatal mode of consumption to a goal-directed/posterior dorsomedial striatal mode to a chronic habitual/compulsive mode involving anterior dorsolateral striatal dopaminergic neurotransmission (Everitt and Robbins, 2013; Furlong et al., 2014; Murray et al., 2012) . In primates, there is a similar evolution of cocaine-induced decrements in both striatal function and dopaminergic neurotransmission, particularly decrements in dopamine D2-like receptor levels (Nader et al., 2008; Porrino et al., 2004) . In humans with substance addiction, as well as in animal models of compulsive drug and food intake/binge-eating, there are decreased striatal dopamine D2-like receptor levels, decreased striatal dopaminergic release, and increased reward thresholds (Avena, 2010; Johnson and Kenny, 2010; Lee et al., 2009; Martinez et al., 2012; Volkow et al., 1993; Volkow et al., 1996) . Decreased striatal dopamine D2-like receptor levels have been inversely correlated with impulsivity in human methamphetamine abusers (Lee et al., 2009 ). In contrast, PET studies with the dopamine D3 preferring radioligand, [ 11 C]PHNO, which selectively labels dopamine D3 receptors in the substantia nigra, report increased nigral dopamine D3 receptor levels in cocaine and methamphetamine abuse that was positively correlated with impulsiveness and risky decision making (Boileau et al., 2012; Payer et al., 2014) ; similarly nigral dopamine D3 receptor levels were positively correlated with impulsiveness in pathological gamblers although mean nigral dopamine D3 receptor levels did not differ from those in healthy individuals (Boileau et al., 2013) .
Rodents fed a high-sugar/high-fat "cafeteria-style" diet become obese and demonstrate elevated reward thresholds and decreased NAc dopamine release (Geiger et al., 2009; Johnson and Kenny, 2010) . In human cocaine-dependent individuals, decreased dopamine release in the anterior caudate and NAc correlated with abnormal reward behavior, particularly preference of cocaine versus monetary reward (Martinez et al., 2007) . The development of compulsive food intake/binge-eating was accelerated in obese rats fed a cafeteria-style diet when dorsolateral striatal dopamine D2 receptor levels were decreased using a lentivirus-induced knockdown approach (Johnson and Kenny, 2010) . Similarly, rodents intermittently exposed to a sugar solution develop sugarbingeing/addiction but do not become obese (Avena, 2010) ; these sugar-bingeing rodents have decreased dorsal striatal dopamine D2-like receptor levels and increased -opioid and dopamine D1-like receptor levels in the NAc (Avena, 2010; Colantuoni et al., 2001) . In contrast, genetic upregulation of striatal D2-like receptor levels in rats trained to self-administer cocaine significantly decreases cocaine self-administration (Thanos et al., 2008) . While a cafeteriastyle diet may produce obesity, elevated reward thresholds, and decreased dopamine release, it is the development of decreased dopamine D2-like receptor levels, particularly in the dorsolateral striatum, which appears to lead to compulsive food and drug use. In animal models, obesity and binge-eating can be produced separately and are associated with dissociable changes in dopaminergic neurotransmission. The function of GABAergic systems within the NAc has also been demonstrated to play an important role in the regulation of impulsivity in rats selected for high or low impulsivity (Caprioli et al., 2014) , so it is conceivable that changes in NAc inhibitory GABA function may be of importance in the increased impulsivity in BED by virtue of its role in integrating dopaminergic neurotransmission.
Direct and indirect striatonigral pathways
The onset of compulsive behaviors appears to relate to an altered balance of signaling between the direct and indirect striatonigral pathways. Dopamine D1 receptors, which are linked to reward, are largely located in the direct striatonigral pathway; dopamine D2 receptors, which are linked to behavioral flexibility, are largely confined to the indirect pathway (Kenny et al., 2013; Nakanishi et al., 2014) . Hypofunction of the indirect pathway is linked to perseverative and compulsive behaviors. In animal models of compulsive food and drug abuse, as well as in human studies of dopamine D1-like and D2-like receptors in cocaine-use disorders, both decreased striatal dopamine D2-like and increased or unchanged levels of dopamine D1-like receptors are observed, consistent with relatively increased signaling in the direct versus indirect pathways (Colantuoni et al., 2001; Furlong et al., 2014; Kenny et al., 2013; Martinez et al., 2004 Martinez et al., , 2009 Nader et al., 2002; Park et al., 2013) . This imbalance in signaling through the direct and indirect striatonigral pathways associated with decreased dorsolateral striatal dopamine D2-like receptor levels, in combination with relatively higher dopamine D1-like receptor signaling, may mediate the development of compulsive drug and food intake.
While multiple studies in animals demonstrate a role for dopaminergic neurotransmission in binge-eating behaviors, there is only a single study of dopaminergic neurotransmission in BED individuals (Wang et al., 2011) . While this study concluded that obese BED individuals had increased dopamine release in the caudate, the study was limited by the small number of participants (10 obese BED and 8 obese non-BED individuals) and questions regarding the confounding effects of methylphenidate, which the authors reported using to amplify the effects of visual food stimuli (Wang et al., 2011) . [ 11 C]Raclopride positron emission tomographic (PET) studies were performed in a baseline state, following visual food stimuli, and following methylphenidate administration with and without visual food stimuli (Wang et al., 2011) . The difference between dopamine D2-like receptor levels after methylphenidate administration with food stimuli compared with baseline levels (without methylphenidate) was used to estimate food-stimuli-induced dopamine release (Wang et al., 2011) . However, this comparison confounds the effects of methylphenidate with food stimuli. This study also reported no difference in baseline dopamine D2-like receptor levels in striatal subregions between obese BED and obese non-BED individuals (Wang et al., 2011) . This lack of a significant difference in striatal dopamine D2-like receptor levels, which has been reported in animal models, may reflect a lack of power due to the small cohort size and/or species differences. In regard to other neurotransmitters which are of interest in BED, there has been a single [ 123 I]nor-␤-CIT study of midbrain serotonin transporters in binge-eating individuals that reported reduced levels (Kuikka et al., 2001) . Although [ 123 I]nor-␤-CIT has been used as a tracer for measurement of serotonin transporters, it has high affinity for the dopamine transporter and midbrain uptake may reflect levels of both serotonin and dopamine transporters (Bergstrom et al., 1997; Oya et al., 1999) .
Although to date there has been little evidence for a role of dopaminergic systems in binge-eating in BED individuals, a role for dopamine systems in the impulsivity and addictive behavior is better defined. Impulsivity was correlated with ventral striatal dopamine D2-like receptor levels in rodents (Belin et al., 2008) , but with ventral midbrain dopamine D2-like receptor levels in humans (Buckholtz et al., 2010) . Further studies of dopamine neurotransmission in BED are needed, and aspects of dopamine function that have been linked to impulsivity warrant consideration in this regard (Boileau et al., 2013; Payer et al., 2014; Potenza and Brody, 2013) . Although an in-depth discussion of the role of dopaminergic transmission in obesity is beyond the scope of this review, it is worth noting that alterations in dopaminergic tone and phasic dopaminergic signaling have been implicated in mediating the behavioral characteristics of obesity (Horstmann et al., 2015; Kessler et al., 2014) .
Alterations in hedonic and reward-related responses and observed brain activity patterns in reward-related areas in individuals with BED share similarities with those in substance-use disorders and addictions. Additionally, diminished control over eating and self-sustaining aspects of binge-eating are reminiscent of the behavioral features of addiction (Bello and Hajnal, 2010; Gearhardt et al., 2011; Mathes et al., 2009 ). The concept, neurobiology, and clinical utility of "food addiction" represents an ongoing area of research (Hebebrand et al., 2014; Meule, 2015; Meule and Gearhardt, 2014; Potenza and Grilo, 2014 ) that has been investigated in regard to BED based on the observation that there are common neurobiological substrates for BED and addiction (Brownell and Gold, 2012; Gearhardt et al., 2011) . Although the topic remains controversial Ziauddeen et al., 2012a,b) , it is worth noting that BED individuals who score high on the Yale Food Addiction Scale (YFAS), which was developed to assess the concept of food addiction (Gearhardt et al., 2009) , report more severe binge-eating pathology than those with lower YFAS scores, and food addiction as indexed by the YFAS is prominent among BED individuals . Further research is needed to clarify more definitively the relationship between food addiction and binge eating in BED.
Summary
The neurobiological basis of BED is slowly being elucidated. Specifically, BED individuals exhibit increased impulsivity, compulsivity, and altered reward sensitivity (Galanti et al., 2007; Manwaring et al., 2011; Schag et al., 2013; Wu et al., 2013) , along with enhanced attentional biases directed toward food and impaired cognitive function (Boeka and Lokken, 2011; Duchesne et al., 2010; Mobbs et al., 2011; Schmitz et al., 2014; Svaldi et al., 2014) . As schematically outlined in Fig. 2 , the neurobehavioral profile observed in BED appears to be subserved by brain regions, including the ventral striatum, which underlies goalseeking behaviors, motivation, and reward sensitivity; the dorsal striatum, which underlies habitual and compulsive behaviors; the prefrontal cortex, which underlies executive function (Berridge and Kringelbach, 2008; Bromberg-Martin et al., 2010; Everitt and Robbins, 2013; Miller and Cohen, 2001) ; and the insula, which underlies interoception, decision-making, taste perception, and feeding regulation (Naqvi and Bechara, 2010; Small, 2010) . These regions may relate to BED in a similar manner as they do to addictions and impulse-control disorders (Arnsten, 2011; Greenberg et al., 2010; Hyman et al., 2006; Li and Sinha, 2008; Morein-Zamir and Robbins, 2014) .
Although multiple neurotransmitter systems (dopaminergic, serotonergic, cholinergic, noradrenergic, GABAergic, opioidergic, and glutamatergic systems) are likely involved in the neuropathophysiology of BED, human neuroimaging (Balodis et al., 2015) and animal (Kenny et al., 2013) studies suggest that altered dopamine function is an important contributor to BED and binge-eating Table 2 Future areas of research.
• Clinical neuroimaging assessment of the neurochemical basis of BED • Utilize PET to examine endogenous DA, NE, 5-HT, opiate and other systems (e.g., gluamatergic) in the striatum and cortex of obese individuals with versus without BED and to assess changes in these neurotransmitter systems after pharmacological pertubations (e.g., following amphetamine challenge) or behavioral and/or pharmacological interventions (i.e., during specific therapies) for BED
• Clinical neuroimaging assessment of cognitive functioning in BED • Utilize FMRI to examine functional activity in and connectivity patterns in regions of the striatum (dorsal versus ventral) and cortex of obese individuals with versus without BED at baseline and following pharmacological pertubations or behavioral and/or pharmacological interventions for BED during the performance of specific cognitive tasks or at rest • Utilize structural measures (e.g., volumetric and diffusion-weighted MRI) to examine differences in obese individuals with versus without BED at baseline and following behavioral and/or pharmacological interventions for BED
• Clinical neuroimaging assessment of the role of stress and emotional regulation in BED • Utilize FMRI to examine functional activity in regions of the striatum (dorsal versus ventral) and cortex of obese individuals with versus without BED at baseline and following pharmacological pertubations or behavioral and/or pharmacological interventions in response to stress • Utilize FMRI to examine functional activity in regions of the striatum (dorsal versus ventral) and cortex as it relates to stress and emotional regulation in obese individuals with versus without BED behaviors. We hypothesize that binge-eating reflects an imbalance between the direct striatonigral output pathway (and its associated D1-like receptors that underlie reward) and the indirect striatopallidal pathway (and its associated D2-like receptors that underlie behavioral flexibility) (Kenny et al., 2013; Nakanishi et al., 2014) . The putative hypofunction of the indirect pathway, as reflected by the reduced D2-like receptor levels reported in animal models of binge-eating (Kenny et al., 2013) , relative to the direct pathway may in part mediate the compulsive eating behaviors seen in BED (Fig. 3) . In animals models of drug abuse, the development of this imbalance may result from chronically increased dopamine release (Nakanishi et al., 2014) ; in animal models of binge-eating behaviors, restricted access to highly palatable foods produces similar patterns of altered dopaminergic neurotransmission (Avena, 2010) and may lead to the development of binge-eating behaviors.
There is a currently a paucity of neuroimaging studies of cerebral neurotransmission in humans with BED and of studies describing the effects of therapeutic agents on corticostriatal activity in BED individuals (Balodis et al., 2015) . As such, potential future research directions in this area are summarized in Table 2 . In this regard, it is worth noting that while evidence indicates that stress and emotional regulation may play a role in BED (Corwin et al., 2011; Gianini et al., 2013; Gluck et al., 2004; Hilbert et al., 2011; Laessle and Schulz, 2009 3 . Cortical/basal-ganglionic/thalamic pathways involved in reward-related feeding behaviors. "Normal" reward-related feeding behavior is shown on the left side of figure. The transition to binge-eating behaviors involves a transition from a ventral-striatal reward-based mode of reward-related food consumption to a dorsal-striatal impulsive/compulsive mode of reward-related food consumption. This adaptive change is proposed to involve decreased cortical inhibition of reward-related food consumption, decreased reward sensitivity related to decreased striatal dopamine release, and an imbalance in the function of the indirect versus direct striatonigral pathways, which is hypothesized to underlie compulsive food intake. The development of decreased striatal dopamine D2-like receptor expression has been associated with hypofunction of the indirect pathway, with relative preservation of the direct pathway function associated with dopamine D1-like receptor signaling leading to binge-type eating behaviors. Red and green lines indicate inhibitory and excitatory pathways, respectively. The red dotted line indicates reduced activity. Black arrows indicate dopamine-containing neurons from the substantia nigra/ventral tegmental midbrain nuclei. PFC-prefrontal cortex; OFC-orbitofrontal cortex; DLC-dorsolateral cortex; insula-insular cortex; D str-dorsal striatum; V str-ventral striatum; D1-dopamine D1-like receptor; D2-dopamine D2-like receptor; Th-thalamus; Sn VTA-substantia nigra, ventral tegmental area nuclei; GPe-globus pallidus external segment; GPi-globus pallidus internal segment; STN-subthalamic nucleus. Pinaquy et al., 2003; Rosenberg et al., 2013; Schulz and Laessle, 2012) , neuroimaging studies in individuals with BED have not been conducted that would link altered stress and emotional regulation in individuals with BED to altered brain function. In conclusion, PET studies of cerebral neurotransmission in BED individuals are needed to more clearly delineate the neurochemistry of BED and how pharmacotherapies may interact with these neurobiological systems to reduce the symptoms of BED. Concurrent fMRI may provide insight into how neurochemical function relates to the cognitive processes underlying BED, and the integration of these approaches into clinical trials will help elucidate the mechanisms of action of specific interventions for BED.
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